2013•Medical Innovation of ChinaRequires access

Therapeutic Effect of Iron Sucrose Combined with Recombinant Human Erythropoietin on Hemodialysis Patients with Moderate Anemia

Pan Jin-li

Abstract

Objective:To observe the efficacy of iron sucrose combined with recombinant human erythropoietin in hemodialysis patients with moderate anemia. Method:Fifty-two maintenance hemodialysis patients with moderate anemia in our hospital from January 2011 to December 2012 were selected.They were treated with iron sucrose and recombinant human erythropoietin.The observing durations were 8 weeks.The levels of hemoglobin, hematocrit and serum ferritin were determined before and after treatment.The side-effects of drugs were also observed.Result:The levels of Hb,Hct, SF after treatment were increased significantly than those before treatment(P0.05).No significant side-effects were found.Conclusion:Iron sucrose combined with erythropoietin can effectively improve moderate anemia in maintenance hemodialysis patients.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Erythropoietin, Iron sucrose, Anemia, Hemoglobin, Hematocrit, Hemodialysis, Sucrose